Skip over navigation
The Hospital
Research
Support Us
Ottawa Hospital Research Institute
Home
Français
Directions & Maps
Contact Us
About Us
Vision and Strategic Directions
Board Chair and CEO Message
Leadership Team
Annual Reports
Facilities
Research Data Management
Equity, Diversity and Inclusion
Wellness
Our Research
Priorities, Programs and Diseases
Researcher Profiles
National Research Networks
Scientific Publications
Research Awards
Technology Transfer
Industry Sponsored Research
Responsible Innovation
For Students & Fellows
News & Events
Newsroom
Seminars & Events
Career Opportunities
For Patients
News & Events
Home
>
News & Events
>
Newsroom
Bookmark or Share
Display Options
Display Options
+
Increase
/
-
Decrease
font size
High contrast version
Printer-friendly version
Newsroom
Seminars & Events
Newsroom
Survey of health care providers and patients highlights need for standardization of use of the Breast Cancer drug, docetaxel.
May 20, 2015
Drs.
Mark Clemons
and
Brian Hutton
have published the results of a survey on the use of steroids to prevent adverse reactions in patients receiving docetaxel chemotherapy, one of the most commonly used drugs in breast cancer. The article, published in
Supportive Care in Cancer
, reports on survey results showing that there are major differences in how the steroids are taken. Both health care providers and patients were asked about their experiences with steroid use in this setting. While 99 percent of patients surveyed believed they were taking the therapy as prescribed, 98 percent of medical practitioners responded knowing of patients who had taken the treatment improperly. Dr. Clemons notes that the survey identified the use of 10 different protocols. “There is a disconnect between health care providers and health care users that needs to be addressed” says Dr. Clemons. “The practice needs to be standardized so that the patient’s understanding of how to take the therapy is communicated effectively.”
Co-authors
: Carmel Jacobs, Sasha Mazzarello, Stephanie Smith, Anil Joy, Eitan Amir, Mohammed F. K. Ibrahim, Nancy Gregario, Kelly Daigle, Lori Eggert
Ottawa Hospital Research Institute
The
Ottawa Hospital Research Institute
is the research arm of
The Ottawa Hospital
and is an affiliated institute of the
University of Ottawa
, closely associated with its faculties of Medicine and Health Sciences. The Ottawa Hospital Research Institute includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease. Support our research. Give to the
Tender Loving Research
campaign.
For further information, please contact
Lois Ross
Senior Communications Specialist
Ottawa Hospital Research Institute
Office: 613-737-8899 x73687
Cell: 613-297-8315
loross@ohri.ca